enfortumab vedotin,erdafitinib
seagen,astellas,janssen
['erdafitinib', ' ev ', ' erda']
nice data, but unfortunetely not definitive for this population. we have nice ev and for fgfr+ patients erdafitinib data too. for this, even more rare patients, this question is still open #esmo2022 
Scientific Committee Member LACOG - GU. Medical Oncologist at Hospital Albert Einstein and CPO. Owner and founder BIO. Following or RT does not mean endorsement